Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS44042872HTLV-1ENSG00000142192.22protein_codingAPPNoNo351A0A0A0MRG2
E9PG40
P05067
TVIS44042875HTLV-1ENSG00000142192.22protein_codingAPPNoNo351A0A0A0MRG2
E9PG40
P05067
TVIS44035325HTLV-1ENSG00000142192.22protein_codingAPPNoNo351A0A0A0MRG2
E9PG40
P05067
TVIS44051683HTLV-1ENSG00000142192.22protein_codingAPPNoNo351A0A0A0MRG2
E9PG40
P05067
TCGA Plot Options
Drug Information
GeneAPP
DrugBank IDDB01593
Drug NameZinc
Target IDBE0003392
UniProt IDP05067
Regulation Typecofactor
PubMed IDs24855651
CitationsMayer MC, Kaden D, Schauenburg L, Hancock MA, Voigt P, Roeser D, Barucker C, Than ME, Schaefer M, Multhaup G: Novel zinc-binding site in the E2 domain regulates amyloid precursor-like protein 1 (APLP1) oligomerization. J Biol Chem. 2014 Jul 4;289(27):19019-30. doi: 10.1074/jbc.M114.570382. Epub 2014 May 22.
GroupsApproved; Investigational
Direct ClassificationHomogeneous transition metal compounds
SMILES[Zn]
PathwaysDihydropyrimidinase Deficiency; Rofecoxib Action Pathway; Losartan Action Pathway; AICA-Ribosiduria; Canavan Disease; Quinapril Action Pathway; Alkaptonuria; Eprosartan Action Pathway; gamma-Glutamyltransferase Deficiency; Pterine Biosynthesis; Sulindac Action Pathway; Rescinnamine Action Pathway; Piroxicam Action Pathway; Nabumetone Action Pathway; 2-Hydroxyglutric Aciduria (D and L Form); beta-Ureidopropionase Deficiency; Vitamin B6 Metabolism; Retinol Metabolism; Valsartan Action Pathway; Valdecoxib Action Pathway; Irbesartan Action Pathway; Adenosine Deaminase Deficiency; Hawkinsinuria; Methionine Metabolism; Ramipril Action Pathway; Benazepril Action Pathway; beta-Alanine Metabolism; Aspartate Metabolism; Diclofenac Action Pathway; Galactosemia
PharmGKBPA451956
ChEMBLCHEMBL1201279